Stockreport

ImmunoPrecise and Biotheus partner on bispecific antibodies to treat cancer [Yahoo! Finance]

ImmunoPrecise Antibodies Ltd.  (IPA) 
PDF material transfer and evaluation agreement (MTEA) with Biotheus on bispecific antibodies to treat cancer. The agreement focuses on the development of a new bispecific [Read more]